Dashboard
Manage Tickers

AKYAAkoya Biosciences, Inc.

Nasdaq akoyabio.com


$ 2.80 $ -0.11 (-3.79 %)    

Wednesday, 15-May-2024 15:58:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.79
$ 2.88
$ 0.00 x 0
$ 8.00 x 100
$ 2.76 - $ 2.88
$ 2.75 - $ 8.80
677,231
na
137.23M
$ 1.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-04-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-19-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
Canaccord Genuity Maintains Buy on Akoya B...
05/14/2024 17:32:14

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from ...

why-alibaba-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Alibaba Shares Are Trading Lower By Ar...
05/14/2024 17:30:43

btig-maintains-buy-on-akoya-biosciences-lowers-price-target-to-6
BTIG Maintains Buy on Akoya Biosciences, L...
05/14/2024 17:01:49

BTIG analyst Mark Massaro maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and lowers the price target from $9 to $6.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 16:31:13

why-alcon-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket
Why Alcon Shares Are Trading Higher By Ove...
05/14/2024 12:30:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 12:06:42

akoya-biosciences-cuts-fy24-revenue-forecast-from-114m-118m-to-104m-112m-est-115767m
Akoya Biosciences Cuts FY24 Revenue Foreca...
05/13/2024 20:38:26

Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

akoya-biosciences-q1-2024-adj-eps-039-misses-029-estimate-sales-18350m-miss-24281m-estimate
Akoya Biosciences Q1 2024 Adj EPS $(0.39) ...
05/13/2024 20:14:50

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $...

akoya-biosciences-and-neracare-enter-exclusive-agreement-to-enable-personalized-therapy-selection-for-early-stage-melanoma-patients
Akoya Biosciences And NeraCare Enter Exclu...
05/09/2024 13:02:28

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for ...

akoya-biosciences-and-shanghai-kr-pharmtech-announce-chinese-regulatory-agency-premarket-approval-for-kr-ht5-in-china-to-support-next-generation-pathology-clinical-workflows
Akoya Biosciences And Shanghai KR Pharmtec...
05/02/2024 12:19:37

Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing mol...

jp-morgan-maintains-overweight-on-akoya-biosciences-lowers-price-target-to-10
JP Morgan Maintains Overweight on Akoya Bi...
03/06/2024 16:06:20

JP Morgan analyst Tycho Peterson maintains Akoya Biosciences (NASDAQ:AKYA) with a Overweight and lowers the price target fro...

ubs-maintains-buy-on-akoya-biosciences-raises-price-target-to-75
UBS Maintains Buy on Akoya Biosciences, Ra...
03/05/2024 14:44:40

UBS analyst John Sourbeer maintains Akoya Biosciences (NASDAQ:AKYA) with a Buy and raises the price target from $7 to $7.5.

canaccord-genuity-reiterates-buy-on-akoya-biosciences-maintains-10-price-target
Canaccord Genuity Reiterates Buy on Akoya ...
03/05/2024 13:58:22

Canaccord Genuity analyst Kyle Mikson reiterates Akoya Biosciences (NASDAQ:AKYA) with a Buy and maintains $10 price target.

akoya-biosciences-sees-fy24-revenue-114m-118m-vs-11738m-est
Akoya Biosciences Sees FY24 Revenue $114M-...
03/04/2024 21:40:32

2024 Financial OutlookThe Company, based on its current plans and initiatives, expects full year 2024 revenue guidance range of...

recap-akoya-biosciences-q4-earnings
Recap: Akoya Biosciences Q4 Earnings
03/04/2024 21:15:10

akoya-biosciences-q4-2023-gaap-eps-022-beats-028-estimate-sales-2649m-beat-2589m-estimate
Akoya Biosciences Q4 2023 GAAP EPS $(0.22)...
03/04/2024 21:15:05

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-march-4-2024
Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

earnings-outlook-for-akoya-biosciences
Earnings Outlook For Akoya Biosciences
03/01/2024 15:01:18

akoya-biosciences-announces-preliminary-financial-results-for-q4-and-fy23-and-provides-2024-outlook-sees-q4-revenue-255m-265m-vs-2628m-est-fy23-revenue-956m-966m-vs-966m-est-expects-fy24-revenue-to-grow-20
Akoya Biosciences Announces Preliminary Fi...
01/07/2024 20:18:14

Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited re...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION